Work

Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined With Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial

Year: 2026

Type: article

Study design: Clinical Trial

Source: The Journal of Urology

DOI: 10.1097/ju.0000000000004993

Authors: Shun Zhang, Tianhang Li, Danyan Li, Yue Yin, Wenjie Zhu, Ning Jiang, Shiwei Zhang, Rong Yang, Hongqian Guo

Institutions: Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Nanjing University, Zhongda Hospital Southeast University, Southeast University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129541244

FWCI:

Cites:

Cited by:

Related to: